Treatment of Neurocysticercosis with Flubendazole

Edmundo Téllez-Girón Departamento de Bioquímica

Search for other papers by Edmundo Téllez-Girón in
Current site
Google Scholar
PubMed
Close
,
Martha C. Ramos Departamento de Bioquímica

Search for other papers by Martha C. Ramos in
Current site
Google Scholar
PubMed
Close
,
Leticia Dufour Departamento de Bioquímica

Search for other papers by Leticia Dufour in
Current site
Google Scholar
PubMed
Close
,
Margarita Montante Departamento de Bioquímica

Search for other papers by Margarita Montante in
Current site
Google Scholar
PubMed
Close
,
Edmundo Téllez Jr. Departamento de Bioquímica

Search for other papers by Edmundo Téllez Jr. in
Current site
Google Scholar
PubMed
Close
,
Jerónimo Rodríguez Departamento de Neurología, Escuela de Medicina, Universidad Autónoma de San Luis Potosí, México

Search for other papers by Jerónimo Rodríguez in
Current site
Google Scholar
PubMed
Close
,
Francisco Gómez Méndez Departamento de Neurología, Escuela de Medicina, Universidad Autónoma de San Luis Potosí, México

Search for other papers by Francisco Gómez Méndez in
Current site
Google Scholar
PubMed
Close
, and
Enrique Mireles Departamento de Neurología, Escuela de Medicina, Universidad Autónoma de San Luis Potosí, México

Search for other papers by Enrique Mireles in
Current site
Google Scholar
PubMed
Close
Restricted access

Thirteen patients with neurocysticercosis were studied and treated with flubendazole. Diagnostic procedures included computerized tomography (CT) and enzyme-linked immunosorbent assay. In 12 cases treatment with the drug led to clinical improvement. CT showed that some cysts regressed in size, and in two patients they disappeared. The treatment also lowered the antibody levels. The drug was well tolerated and no allergic reaction or other side effects were observed.

Author Notes

Save